Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03377530
Other study ID # CHRD1715
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2008
Est. completion date August 31, 2016

Study information

Verified date July 2019
Source Centre Hospitalier René Dubos
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Bacillus species are ubiquitous gram-positive spore-forming organisms. They rarely cause disease in the immunocompetent and are more frequently isolated as a culture contaminant. However, Bacillus Species can cause severe systemic infections in immunocompromised patients including preterm infants.

The purpose of this study is to identify the risk factors of these infections.


Description:

Non-anthrax Bacillus Species bacteria can be responsible for food poisoning and local infections. Rarely, they lead to severe infections like blood stream infections and meningitis especially in immunocompromised patients like preterm infants.

Bacillus Cereus is the most common members of the genus Bacillus. Only few reports studied these systemic infections in premature neonates. In order to identify the risk factors for severe Bacillus Species infections, we studied retrospectively eleven cases of these infections in our NICU and reviewed series and report cases in literature.


Recruitment information / eligibility

Status Completed
Enrollment 11
Est. completion date August 31, 2016
Est. primary completion date August 31, 2016
Accepts healthy volunteers
Gender All
Age group N/A to 28 Days
Eligibility Inclusion Criteria:

- cases of Bacillus Species sepsis

- cases of Bacillus species meningitis

- with significant change in clinical status

- Bacillus Species is the only organism isolated

Exclusion Criteria:

- Bacillus Species isolated with other organisms and Bacillus Species without clinical change were considered to be contaminants

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Ways to prevent these infections.
The purpose of this database is to describe the pathogenicity of this germ, the incriminated modes of contamination. The collaborators studied the factors of poor prognosis and propose ways to prevent these infections.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier René Dubos

Outcome

Type Measure Description Time frame Safety issue
Primary Severe infection rate due to Bacillus Sp germ The purpose of this database is to mesure the pathogenicity of this germ based on the severe infection rate Through study completion, an average of 1 year.
Secondary To collecte the incriminated modes of contamination. The purpose of this database is to describe the incriminated modes of contamination. Through study completion, an average of 1 year.
See also
  Status Clinical Trial Phase
Completed NCT06328634 - Bacillus Cereus Infection of Patients Diagnosed at Nîmes University Hospital